Open Your FREE Demat Account Now!

Global Health Ltd. Share Price

NSE
BSE

NSE : MEDANTA

BSE : 543654

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Low

₹1,270.90

High

₹1,309.30

Price Summary

Previous Close ₹1,276.50
Day's Range ₹1,270.90 - ₹1,309.30
Open ₹1,299.00
52 Week Range ₹956.00 - ₹1,544.00
Volume 1,44,593
Market Cap ₹0.03
Previous Close ₹1,278.00
Day's Range ₹1,272.55 - ₹1,308.55
Open ₹1,300.05
52 Week Range ₹955.20 - ₹1,542.00
Volume 2,540
Market Cap ₹0.03

Stocks Summary

Trade Value ( ₹ in Lacs) 1,845.73
Market Cap (₹ in Mn) 0.03
Dividend Yield(%) 0.04
Price/Earning (TTM) 61.69
TTM EPS (₹) 20.69
P/E Ratio 46.44
Book Value(₹) 8.34
PAT Margin (%) 12.56
Face Value (₹) 2.00
ROCE(%) 19.38
Trade Value ( ₹ in Lacs) 32.46
Market Cap (₹ in Mn) 0.03
Dividend Yield(%) 0.04
Price/Earning (TTM) 61.69
TTM EPS (₹) 20.69
P/E Ratio 46.44
Book Value(₹) 8.34
PAT Margin (%) 12.56
Face Value (₹) 2.00
ROCE(%) 19.38

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 10308.44 32041.46
Expenses N/A N/A
PBT 2081.41 6230.47
Operating profit 0.0 0.0
Net profit 1589.82 4615.28

Shareholding Pattern

Promoters (% Holding)

33.00%

Mutual funds (% Holding)

16.03%

Non-Institution (% Holding)

40.65%

FI/Banks/Insurance (% Holding)

0.66%

Government (% Holding)

0.00%

FII

9.46%

About Global Health Ltd.

Founded 2004
Managing Director Naresh Trehan
NSE Symbol MEDANTA

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd. 4,20,483.45 1,752.50 1,583.70 - 1,583.70
Divi's Laboratories Ltd. 2,49,248.45 9,389.00 5,647.50 - 5,647.50
Torrent Pharmaceuticals Ltd. 1,77,821.97 4,675.00 3,480.60 - 3,480.60
Lenskart Solutions Ltd. 1,13,750.62 656.45 0.00 - 0.00
Zydus Lifesciences Ltd. 1,11,241.63 1,115.20 835.50 - 835.50
Apollo Hospitals Enterprise Ltd. 1,10,239.70 7,667.00 6,696.50 - 6,696.50
Laurus Labs Ltd. 1,08,062.44 2,000.00 843.00 - 843.00
Cipla Ltd. 1,05,427.12 1,305.00 1,165.70 - 1,165.70
Mankind Pharma Ltd. 99,064.73 2,398.40 1,909.70 - 1,909.70
Dr. Reddy's Laboratories Ltd. 98,492.27 1,180.00 1,101.00 - 1,101.00
no-content No Records Found

Latest News

Oct
8
2026
EQUITY Posted on Oct 8th 2026

RPG Life Sciences informs about certificate

RPG Life Sciences has informed that it enclosed certificate dated October 03, 2026 issued by MUFG Intime India, Registrar and Transfer Agents, confirming compliance under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018.
The above information is a part of company’s filings submitted to BSE. 
Read More
Oct
8
2026
EQUITY Posted on Oct 8th 2026

Viyash Scientific informs about allotment of equity shares

Viyash Scientific has informed that the Nomination and Remuneration Committee of the Company vide resolution passed by circulation on October 08, 2026, has approved the allotment of 1,35,880 equity shares of face value Rs. 2/- each, fully paid up, pursuant to the exercise of stock options under the Sequent Scientific Limited Employee Stock Option Plan 2020 (“Sequent ESOP 2020”) and the Viyash Scientific Limited Employee Stock Option Scheme 2026 (“Viyash ESOP 2026”), as detailed below: a. 79,000 equity shares at an exercise price of Rs. 86 per equity share to eligible optionees under Sequent ESOP 2020. b. 56,880 equity shares at an exercise price of Rs.101 per equity share to eligible optionees under Viyash ESOP 2026. The aforesaid equity shares shall rank pari passu in all respects with the existing equity shares of the Company. Consequent to the aforesaid allotment, the issued and paid-up equity share capital of the Company has increased from Rs. 88,32,55,340/- consisting of 44,16,27,670 Equity Shares of Rs. 2 each to Rs. 88,35,27,100, comprising of 44,17,63,550 Equity Shares of Rs. 2 each.
The above information is a part of company’s filings submitted to BSE.
Read More
Oct
8
2026
EQUITY Posted on Oct 8th 2026

Fredun Pharmaceuticals informs about press release

Fredun Pharmaceuticals has informed that it enclosed press release titled ‘Fredun Pharmaceuticals Accelerates into a HighGrowth Branded Healthcare Platform’ Two Strategic Pet-Care Deals, Premium Wellness Launches, Capacity Expansion & Bonus Issue Position Company for the Next Leg of Growth issued by the company. 
The above information is a part of company’s filings submitted to BSE. 
Read More
Oct
7
2026
EQUITY Posted on Oct 7th 2026

Aashka Hospitals informs about confirmation certificate

Aashka Hospitals has informed that it enclosed the confirmation certificate received from Accurate Securities & Registry, Registrar and Share Transfer Agent (RTA) as per Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
The above information is a part of company’s filings submitted to BSE. 
Read More
Oct
7
2026
EQUITY Posted on Oct 7th 2026

Dishman Carbogen Amcis informs about outcome of board meeting

Dishman Carbogen Amcis has informed that the Board of Directors of the Company has at its meeting held today, Wednesday, October 7, 2026 which was commenced at 13:30 pm and concluded at 14:10 pm, approved; issuance of senior, secured, rated, listed, transferable, redeemable, taxable non-convertible debentures aggregating up to Rs 38 crores; modification/amendment in security in respect of the company's tranche ii of 1,500 senior, secured, rated, listed, transferable, redeemable, taxable non- convertible debentures of face value of Rs 1,00,000 each, aggregating to Rs 15 crore, allotted on september 28, 2026 having scrip code 978230.
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Global Health Ltd. ?

The current share price of Global Health Ltd. is ₹1,276.50 as of 2026-10-08.

The market capitalisation of Global Health Ltd. is ₹34,309.77 as of 2026-10-08.

The 1-year return of Global Health Ltd. is -75.40% as of 2026-10-08.

The P/E ratio of Global Health Ltd. is 46.44 as of 2026-10-08.

The 52-week high and low of Global Health Ltd. are ₹1,544.00 and ₹956.00, respectively, as of 2026-10-08.

The dividend yield of Global Health Ltd. is 0.0392% as of2026-10-08.

You can buy Global Health Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Global Health Ltd. is Naresh Trehan.

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore